AscellaHealth CEO Joins Titan Hall of Fame Amid Growth Run

Titan 100

BERWYN, PA — AscellaHealth co-founder and Chief Executive Officer Dea Belazi has been named a 2026 Philadelphia Titan 100 Hall of Fame honoree, recognition that follows several years of rapid growth for the specialty healthcare company and its expanding global footprint.

The Hall of Fame designation is awarded to executives who have earned Titan 100 recognition for three consecutive years and are selected through an interview and judging process conducted by Titan CEO.

Belazi leads AscellaHealth, a specialty healthcare and pharmacy services company that supports life sciences manufacturers, health plans and other healthcare organizations involved in specialty pharmaceuticals and rare-disease treatments.

The recognition comes as specialty drug spending continues to rise across the healthcare industry, increasing demand for pharmacy benefit management, specialty pharmacy and patient-support services aimed at controlling costs and improving treatment access.

READ:  Vasco Audience Wins EdTech Award Amid Demand for Multilingual Outreach

Under Belazi’s leadership, AscellaHealth reports expanding operations into more than 70 countries while broadening its services across market access, distribution, specialty pharmacy and patient-support programs.

The company also reported 753% revenue growth and 167% workforce growth during its expansion, according to information released by the organization.

Earlier this year, AscellaHealth launched AscellaOne, a technology platform designed to support pharmacy benefit operations for payers, employers and pharmacy benefit management organizations.

Belazi stated that the company remains focused on helping healthcare organizations manage specialty drug costs while improving patient outcomes.

READ:  Willig Williams Attorneys Earn Statewide Honors in 2026 Rankings

“As healthcare stakeholders face increasing pressure to manage rising specialty drug costs while improving patient outcomes, AscellaHealth remains focused on delivering innovative pharmacy benefit solutions,” he said.

The Philadelphia Titan 100 program recognizes senior executives from companies across multiple industries in the region. Organizers noted that the 2026 honorees collectively generate more than $71.6 billion in annual revenue and employ more than 78,000 people.

Belazi is scheduled to be recognized during the Philadelphia Titan 100 Awards ceremony on Sept. 10 at 2300 Arena in Philadelphia.

Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.